ArticleCell transplantation

Long-term complete remission and minimal side effects after CD19/CD22 CAR-T cell cocktail therapy in a living donor with DLBCL: A rare case report.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.